Search results for "cytotoxic"

showing 10 items of 1673 documents

Novel Developments on Artemisinin and Its Derivatives for Cancer Therapy

2009

The lack of effective long-term anticancer therapy highlights the necessity to identify new potent anticancer compounds. Many biocompounds of naturally occurring medicinal plants have pharmacological activities and, thus, represent a source of molecules that may have anti-proliferative effects on a variety of cancers. During the past 10 years, we have systematically analyzed medicinal plants used in traditional Chinese medicine and focused our interest on Artemisia annua (sweet wormwood herb). The active principle of sweet wormwood herb is Artemisinin, a sesquiterpene, which exerts not only anti-malarial activity but also profound cytotoxicity against tumour cells. The anti-tumour mechanism…

biologybusiness.industryArtemisia annuaTraditional Chinese medicinePharmacologybiology.organism_classificationchemistry.chemical_compoundchemistryIn vivoArtesunateMedicineArtemisininMedicinal plantsCytotoxicitybusinessMode of actionmedicine.drug
researchProduct

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments

2021

Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral destruction of platelets and an inappropriate bone marrow production. Although the primary triggering factors of ITP remain unknown, a loss of immune tolerance—mostly represented by a regulatory T-cell defect—allows T follicular helper cells to stimulate autoreactive splenic B cells that differentiate into antiplatelet antibody-producing plasma cells. Glycoprotein IIb/IIIa is the main target of antiplatelet antibodies leading to platelet phagocytosis by splenic macrophages, through interactions with Fc gamma receptors (FcγRs) and complement receptors. This allows macrophages to activate autoreactive T cells …

biologybusiness.industryReviewHematologyComplement receptorAntibody opsonizationClassical complement pathwayImmune systemhemic and lymphatic diseasesImmunologybiology.proteinCytotoxic T cellMedicineDiseases of the blood and blood-forming organsPlateletRC633-647.5AntibodybusinessThrombopoietinHemaSphere
researchProduct

GTPases of the Rho Subfamily Are Required for Brucella abortus Internalization in Nonprofessional Phagocytes

2001

Members of the genus Brucella are intracellular -Proteobacteria responsible for brucellosis, a chronic disease of humans and animals. Little is known about Brucella virulence mechanisms, but the abilities of these bacteria to invade and to survive within cells are decisive factors for causing disease. Transmission electron and fluorescence microscopy of infected nonprofessional phagocytic HeLa cells revealed minor membrane changes accompanied by discrete recruitment of F-actin at the site of Brucella abortus entry. Cell uptake of B. abortus was negatively affected to various degrees by actin, actin-myosin, and microtubule chemical inhibitors. Modulators of MAPKs and protein-tyrosine kinases…

biologymedia_common.quotation_subjectIntracellular parasiteBRUCELLA ABORTUSVirulenceCell BiologyCDC42BrucellaGTPasebiology.organism_classificationBiochemistryMicrobiologyBRUCELOSISCytotoxic T cellBRUCELLAESCHERICHIA COLIBACTERIASInternalizationMolecular BiologyIntracellularmedia_commonJournal of Biological Chemistry
researchProduct

Organometallic complexes with biological molecules: XIII. Organotin(IV)[meso-tetra (4-carboxyphenyl)porphinate]s and the cell cycle: a flow-cytometri…

1999

The cytotoxic derivatives diorganotin(IV) and triorganotin(IV) [meso-tetra(4-carboxyphenyl)porphinates, with stoichiometries [R2Sn]2TPPC and [R3Sn]4TPPC [R = Me, Bu, Ph; TPPC4−­= meso-tetra(4-carboxyphenyl)porphinate4−], namely bis[dimethyltin(IV)], bis[dibutyltin(IV)], bis[diphenyltin(IV)], tetra[trimethyltin(IV)], tetra[tributyltin(IV)] and tetra[triphenyltin(IV)] [meso-tetra(4-carboxyphenyl)porphinate]s, have been used to investigate their effects on the cultured human kidney cell cycle in order to understand further the origin of cell-growth inhibition induced by the above-mentioned chemicals. The cell-cycle-dependent DNA content distribution of cultured cells exposed to these compounds…

biologymedicine.diagnostic_testMeso compoundStereochemistryGeneral Chemistrybiology.organism_classificationIn vitroFlow cytometrycarbohydrates (lipids)Inorganic Chemistrychemistry.chemical_compoundchemistryIn vivoCell culturepolycyclic compoundsmedicineTributyltinTetraCytotoxicityApplied Organometallic Chemistry
researchProduct

In Vitro Stimulation and Expansion of Human Tumour-Reactive CD8+ Cytotoxic T Lymphocytes by Anti-CD3/CD28/CD137 Magnetic Beads

2011

Adoptive immunotherapy with tumour-reactive CD8(+) cytotoxic T lymphocytes (CTLs) requires efficient in vitro approaches allowing the expansion of CTLs to large numbers prior infusion. Here, we investigated the antigen-independent activation and the expansion of human T cells in peripheral blood mononuclear cells (PBMCs) and in tumour-reactive CTLs using Dynabeads coated with monoclonal antibodies to CD3 and to the costimulatory molecules CD28 and CD137 (4-1BB). T cells in PBMCs showed an increased expansion rate of 15- to 17-fold during a 2-week culture period using antibody-conjugated beads with interleukin-2 (IL-2) added versus IL-2 alone. No significant difference between CD3/CD28 beads…

biologymedicine.drug_classELISPOTCD3ImmunologyCD28chemical and pharmacologic phenomenahemic and immune systemsGeneral MedicineMonoclonal antibodyMolecular biologyPeripheral blood mononuclear cellDynabeadsmedicinebiology.proteinCytotoxic T cellCD8Scandinavian Journal of Immunology
researchProduct

Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR

2013

CD8(+) T cells have an essential role in controlling lymphocytic choriomeningitis virus (LCMV) infection in mice. Here, we examined the contribution of humoral immunity, including nonneutralizing antibodies (Abs), in this infection induced by low virus inoculation doses. Mice with impaired humoral immunity readily terminated infection with the slowly replicating LCMV strain Armstrong but showed delayed virus elimination after inoculation with the faster replicating LCMV strain WE and failed to clear the rapidly replicating LCMV strain Docile, which is in contrast to the results obtained with wild-type mice. Thus, the requirement for adaptive humoral immunity to control the infection was dep…

biologyvirusesImmunologychemical and pharmacologic phenomenaLymphocytic choriomeningitismedicine.diseaseVirologyVirusNucleoproteinTiterImmunologyHumoral immunitymedicinebiology.proteinImmunology and AllergyCytotoxic T cellAntibodyCD8European Journal of Immunology
researchProduct

Animal models: Murine cytomegalovirus

2002

Publisher Summary This chapter focuses on murine cytomegalovirus (CMV) animal models. Multiple-organ cytomegalovirus disease, interstitial pneumonia in particular, is a major concern in the therapy of hematopoietic malignancies by hematoablative treatment and bone marrow transplantation (BMT). Human CMV (hCMV) is the prototype member of the subfamily, Betaherpesvirinae, of the virus family, Herpesviridae . Its genome is a linear, double-stranded DNA with a coding capacity of ca. 165 open reading frames. During an aeon of co-evolution, CMVs have adapted themselves to their respective hosts; therefore, CMV biology is most reliably studied in a natural virus-host combination. Even though hCMV …

biologyvirusesViral pathogenesisvirus diseasesCytomegalovirusmedicine.disease_causebiology.organism_classificationVirologyHerpesviridaeVirusImmune systemViral replicationBetaherpesvirinaeImmunologymedicineCytotoxic T cell
researchProduct

Synthetic/ECM-inspired hybrid platform for hollow microcarriers with ROS-triggered nanoporation hallmarks

2017

Reactive oxygen species (ROS) are key pathological signals expressed in inflammatory diseases such as cancer, ischemic conditions and atherosclerosis. An ideal drug delivery system should not only be responsive to these signals but also should not elicit an unfavourable host response. This study presents an innovative platform for drug delivery where a natural/synthetic composite system composed of collagen type I and a synthesized polythioether, ensures a dual stimuli-responsive behaviour. Collagen type I is an extracellular matrix constituent protein, responsive to matrix metalloproteinases (MMP) cleavage per se. Polythioethers are stable synthetic polymers characterized by the presence o…

biomedical applicationsPathologyresponsivenessPolymersNanoparticlecardiomyocytes02 engineering and technologyMatrix metalloproteinaseMicroscopy Atomic Force01 natural sciencesreleaseHollow spheresExtracellular matrixDrug Delivery Systemsreactive oxygenCytotoxicitynanomaterialsdegradationchemistry.chemical_classificationDrug CarriersMicroscopyMultidisciplinaryIschemic conditionsQRAtomic ForcePolymerStimuli-responsive021001 nanoscience & nanotechnologyMicrospheresDrug deliveryMedicineROS (Reactive Oxygen Species) inflamed tissue stimuli-responsive biomaterials ischemic conditions hollow spheres polysulfides collagenCollagenhypoxia-reoxygenationdelivery0210 nano-technologyAnimals; Cell Line; Drug Carriers; Drug Delivery Systems; Matrix Metalloproteinases; Microscopy Atomic Force; Microspheres; Polymers; Rats; Reactive Oxygen Speciesmedicine.medical_specialtyROS (Reactive Oxygen Species)ScienceInflamed tissue010402 general chemistryArticleCell LineBiomaterialsPolysulfidesmedicineAnimalsReactive oxygen speciesMicrocarrierMatrix Metalloproteinases0104 chemical sciencesRatschemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsnanoparticlesReactive Oxygen Species
researchProduct

Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Neg…

2015

BC-11 is an easily synthesized simple thiouronium-substituted phenylboronic acid, which has been shown to be cytotoxic on triple negative MDA-MB231 breast cancer cells by inducing a perturbation of cell cycle when administered at a concentration equal to its ED50 at 72 h (117 μM). Exposure of cells to BC-11, either pre-absorbed with a soluble preparation of the N-terminal fragment of urokinase-plasminogen activator (uPa), or in co-treatment with two different EGFR inhibitors, indicated that: (i) BC-11 acts via binding to the N-terminus of the enzyme where uPa- and EGF receptor-recognizing sites are present, thereby abrogating the growth-sustaining effect resulting from receptor binding

boronic acidPharmaceutical ScienceGene ExpressionApoptosisAnalytical ChemistryDrug DiscoveryCytotoxic T cellSettore BIO/06 - Anatomia Comparata E CitologiaCytotoxicityEGFR inhibitorschemistry.chemical_classificationCell CycleDrug SynergismCell cycleBoronic AcidsMitochondriaErbB ReceptorsBiochemistryChemistry (miscellaneous)Molecular MedicinecytotoxicityFemaleQD0241Antineoplastic AgentsArticlelcsh:QD241-441plasminogen activator inhibitorbreast cancerlcsh:Organic chemistryCell Line TumorHumansPhysical and Theoretical ChemistryMammary Glands HumanCell ProliferationQD0415Reactive oxygen speciesHydrobromideOrganic ChemistryEpithelial CellsBC-11Molecular biologyUrokinase-Type Plasminogen ActivatorPlasminogen InactivatorsEnzymechemistryApoptosisQuinazolinesMDA-MB231 cellsReactive Oxygen Speciesboronic acid; BC-11; plasminogen activator inhibitor; breast cancer; cytotoxicity; MDA-MB231 cellsMolecules
researchProduct

JAHA, a novel histone deacetylase inhibitor: cytotoxic effect on triple-negative breast cancer cells

2013

breast cancercytotoxicitySettore BIO/06 - Anatomia Comparata E Citologiahistone deacetylase inhibitor
researchProduct